DÄ internationalArchiveReferences

Review article

Salicylate Intolerance

Dtsch Arztebl Int 2008; 105(8): 137-42. DOI: 10.3238/arztebl.2008.0137

Baenkler, HW

1. Willis AL, Smith DL: Metabolism of arachidonic acid. In: Cunningham FM (ed.): The handbook of immunopharmacology and lipid mediators. London: Academic Press 1994; 1–32.
2. Szczeklik A, Stevenson DD: Aspirin-induced asthma: advances in pathogenesis, diagnosis and management. J Allergy Clin Immunol 2003, 111: 913–20. MEDLINE
3. Farooque S, Lee T: Mechanisms of aspirin-sensitive respiratory disease – as two component Model. Int Arch Allergy Immunol 2007; 142: 59–63. MEDLINE
4. Schäfer D: Testing and typing of eicosanoid-patterns. J Physiol Pharmacol 2006; 57: 47–64. MEDLINE
5. Kaldenbach T, Schäfer D, Gosepath J, Bittinger F, Klimek L, Mann WJ: Die Bedeutung eosinophiler Granulozyten in Beziehung zu Allergie und Aspirin-Intoleranz bei Patienten mit Sinusitis polyposa. Laryngo-Rhino-Otol 1999; 17: 429–34. MEDLINE
6. Sanz ML, Gamboa P, DeWeck A: A new combined test with flowcytometric basophile activation and determination of sulfidoleucotrienes is useful for in vitro diagnosis of hypersensitivity to Aspirin and other NSAID. Int Arch Allergy Immunol 2005; 136: 58–72. MEDLINE
7. Schäfer D, Schmid M, Göde UC, Baenkler HW: Dynamics of eicosanoid in peripheral blood cells during bronchial, in: Aspirin-intolerant asthmatics. Eur Respir J 1999; 13: 638–46. MEDLINE
8. Schiavino D, Nucera E, Milani A, Del Ninno M, Buenomo A, Sun J, Patriarca G: The aspirin disease. Thorax 2000; 55: 66–9. MEDLINE
9. Baenkler HW, Schäfer D, Hosemann W: Eicosanoid pattern in nasal polyps and nasal mucosa. Rhinology 1996; 34: 166–70. MEDLINE
10. Schäfer D, Lindenthal U, Wagner M, Bölcskei PL, Baenkler HW: Effect of prostaglandine E2 on eicosanoid release by human bronchial biopsy specimens from normal and inflamed mucosa. Thorax 1996; 51: 919–23. MEDLINE
11. Schmid M, Göde U, Schäfer D, Wigand ME: Arachidonic acid metabolism in nasal tissue and peripheral blood cells in Aspirin-intolerant asthmatics. Acta Otolaryngol 1999; 119: 227–30. MEDLINE
12. Gosepath J, Hoffmann F, Schäfer D, Amedee RG, Mann WJ: Aspirin-intolerance in patients with chronic sinusitis. ORL 1999; 61: 146–50. MEDLINE
13. Puhlmann U, Schäfer D, Ziemann C: Update on COX-2 inhibitor patents with focus on optimized formulation and therapeutic scope of drug combinations making use of COX-2 inhibitors. Expert Opin Ther Patents 2006; 16: 403–30.
14. Velten FW, Bayerl C, Baenkler HW, Schaefer D: Functional eicosanoid test and typing (FET) in acetylsalicylic acid intolerant patients with urticaria. J Physiol Pharmacol 2006, 57: 35–46. MEDLINE
15. Raithel M, Baenkler HW, Naegel A, Buchwald F, Schultis HW, Backhus B, Kimper S, Koch H, Mach E, Hahn EG, Konturek P: Significance of salicylate-intolerance in diseases of lower gastrointestinal tract. J Physiol Pharmacol 2005; 56: 89–102. MEDLINE
16. May A, Weber A, Gall H, Kaufmann R, Zollner T: Means of increasing sensitivity of an in vitro diagnostic test for aspirin Intolerance. Clin Exp Allergy 1999; 29: 1402–11. MEDLINE
17. Ebo DG, Saint-Laudy A, Birdts CH, Mertens CH, Hagedorens MM, Schuerwegh AJ, De Clerck LS, Stevens WJ: Flow-assisted allergy-diagnosis: current application and future perspectives. Allergy 2006; 61: 1028–39. MEDLINE
18. Gamboa P, Sanz ML, Caballero MR, Urrutia I, Antepara I, Esparza R et al.: The flow-cytometric determination of basophile activation induced by aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) is useful for in vitro diagnosis of the NSAID hypersensitivity syndrome. Clin Exp Allergy 2004; 34: 1448–57. MEDLINE
19. Buhring HJ, Streble A, Valent P: The basophile-specific ectoenzyme E-NPP3 (CD203c) as a marker for cell. Activation and allergy diagnosis. Int Arch Allergy Immunol 2004; 133: 317–29. MEDLINE
20. Hecksteden K, Schäfer D, Stuck BA, Klimek L, Hörmann K: Diagnostik des Analgetika-Intoleranz-Syndroms mittels funktioneller Zelltestung. Allergologie 2003; 26: 263–71.
21. Gosepath J, Schäfer D, Amadee RG, Mann WJ: Individual monitoring of aspirin desensitization. Arch Otolaryngol Head Neck Surg 2001; 12: 316–21. MEDLINE
22. Pfaar O, Klimek L: Aspirin desensitization in aspirin intolerance: update on current standards and recents improvements. Curr Opin Allergy Clin Immunol 2006, 6: 161–6. MEDLINE
23. Schapowal A, Schmitz-Schumann M: Provokationstests bei aspirinsensitivem Asthma und aspirinsensitiver Rhinosinusits. Allergologie 1992: 15: 158–64.
24. Pearson DJ, Stones NA, Bentley SJ, Reid H: Proctocolitis induced by salicylate and associated with asthma and recurrent nasal polyps. Br Med J 1983; 287: 1675 MEDLINE
e1. Bergström S: The prostaglandins: from the laboratory to the clinic. Nobel Lectures. Physiology or Medicine. Berichtszeitraum 1981–1990. Hrsg.: Jan Lindsten 1982; 93–112.
e2. Samuelson B: From studies of biochemical mechanisms to novel biological mediators: prostaglandin endoperoxides, thromboxanes and leukotrienes. Nobel Lectures. Physiology or Medicine. Berichtszeitraum 1981–1990. Hrsg.: Jan Lindsten 1982; 117–38.
e3. Vane JR: Adventures and excursions in bioassays: the stepping stones to prostacyclin. Nobel Lectures. Physiology or Medicine. Berichtszeitraum 1981–1990. Hrsg.: Jan Lindsten 1982; 145–70.
e4. Settipane GA: Aspirin and allergic disease: a review. Am J Med 1983; 74: 102–9. MEDLINE
e5. Szczeklik A, Sanak M, Nizankowski E, Kielbasa B: Aspirin-intolerance and cyclooxygenase-leukotriene pathways. Curr Opin Pulm Med 2004; 10: 51–6. MEDLINE
e6. Szczeklik A, Nizankowska E, Duplaga M: Natural history of aspirin-induced asthma. AJANE investigators European Network of aspirin-induced asthma. Eur Resp J 2000; 16: 432–6. MEDLINE
e7. May A, Zollner T, Weber A, Kaufmann R: Der Cellular Antigen Stimulations Test (CAST) in der Diagnostik Aspirin-sensitiver Rhinosinusitiden. Allergologie 2000; 23: 103–9.
e8. Kahlert H, Cromwell O, Fiebig H: Measurement of basophile-activating capacity of grass pollen allergens, Allergoids and hypoallergenic recombinant derivates by flow cytometry Using anti-CD203c. Int Arch Allergy Immunol 2004; 133: 317–29.
e9. Samter M, Beers RF: Concerning the nature of intolerance to Aspirin. J Allergy 1967; 40: 281–93. MEDLINE
e10. Becker JC, Domschke W, Pohle T: Current approaches to prevent NSAID-induced gastrophathy – COX selectivity and beyond. Br J Clin Pharmacol 2004; 58: 586–600. MEDLINE
e11. Hirschberg: Mitteilung über einen Fall von Nebenwirkungen des Aspirin. DMW 1902; 28: 416.
e12. Widal MF, Abrani P, Lermoyez J: Anaphylaxie et idiosyncrasie. Presse Med 1922; 30; 189–92.
e13. Möller R, Paul E: Acetylsalicylsäure als Augmentationsfaktor bei Nahrungsmittelallergien. Hautarzt 1996; 47: 281–3. MEDLINE
e14. Chakroborty TK, Bhatia D, Heading RC, Ford MJ: Salicylate-induced exacerbation of ulcerative colitis. Gut 1987; 28: 613–5. MEDLINE
e15. Etienney I, Beaugerie L, Viboud C, Flahault A: Non-steroidal anti-inflammatory drugs as a risk factor for acute diarrhoea: A case crossover study. Gut 2003; 52: 260–3. MEDLINE
e16. Higuchi T, Iwama T, Yoshinaga K, Toyooka M, Taketo MM, Sugihave K: A randomized, double blind, placebo controlled trial of the effects of Rolecoxib, a selective COX-2-inhibitor, on rectal polyps in familial adenomatous polyposis patients. Clin Cancer Res 2003, 9: 4756–60. MEDLINE
e17. Baenkler HW, Schäfer D: Abnormal eicosanoid pattern of peripheral white blood cells in gastrointestinal cancer. J Physiol Pharmacol 2005; 56: 119–28. MEDLINE
e18. Konturek S, Piastucki I, Brzozowski T, Rodecki T, Dembinska-Kiec A, Zmuda A, Gryglewski R: Role of prostaglandins in the formation of Aspirin-induced gastric ulcer. Gastroenterology 1981; 80: 4–9. MEDLINE
e19. Baenkler HW, Zeus J, Schenk J, Schäfer D: Abnormal eicosanoid pattern by blood leukocytes in gastroduodenal ulcer. Med Science Monitor 2004; 10: 447–56. MEDLINE
e20. Gosepath J, Schäfer D, Mann WJ: Analgetika-Intoleranz: Langzeitergebnisse bis zu 3 Jahren bei adaptativer Desaktivierung mit einer täglichen Erhaltungsdosis von 100 mg Aspirin. Laryngo-Rhino-Otol 2002; 81: 732–8. MEDLINE
e21. Erdmann SM, Vetocilla S, Moll-Slodowy S, Sauer I, Merk HF: Basophilen-Aktivierungstest in der Diagnostik von Arzneimittelrekationen. Hautarzt 2005; 56: 38–43. MEDLINE
e22. Baenkler M, Leykauf M, John S: Functional analysis of eicosanoids from white blood cells in sepsis and SIRS. J Physiol Pharmacol 2006; 57: 25–34. MEDLINE
e23. Häberle M: Klinische und lebensmittelchemische Aspekte bei Unverträglichkeitsreaktionen auf Salizylat- und Additive-haltige Lebensmittel. Zbl Haut 1987; 153: 75–95.
e24. Thun MJ, Heuby SJ, Patrono C: NSAID as anticancer agents: mechanistic, pharmacologic and clinical issues. J Natl Cancer Inst 2002; 94: 252–66. MEDLINE
e25. Blacklock CJ, Lawrence JR, Wiles D, Malcolm EA, Gibson JH, Kelly CJ, Peterson JR: Salicylic acid in the serum of subjects not taking Aspirin. Comparison of salicylic acid concentrations in the serum of vegetarians, non-vegetarians and patients taking low dose Aspirin. J Clin Pathol 2001; 54: 553–5. MEDLINE
e26. Steinmetz KA, Potter JD: Vegetables, fruit and cancer: Epidemiology Cancer Causes Control 1991; 2: 325–47. MEDLINE
e27. Calder PC: Immunomodulatory and anti-inflammatory effects of n-3 polyunsaturated fatty acids. Proc Nutr Soc 1996; 95: 727–34. MEDLINE
e28. Rodgers JB: n-3 fatty acids in the treatment of ulcerative colitis. In: Kremer J (ed.): Medical fatty acids in inflammation. Basel: Birkhäuser Verlag 1998: 91–101.
e29. Cleland LG, James MJ, Proudman SM: The role of fish oils in the treatment of rheumatoid arthritis. Drug 2003; 63: 845–53. MEDLINE
e30. Swank RL, Dugan BB: Effect of low saturated fat diet in early and late cases of multiple sclerosis. Lancet 1990; 336: 37–9. MEDLINE